Reports
Sale
Global Cell and Gene Therapy Cold Chain Logistics Market Size, Share, Growth, Forecast: By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra Low Freezers, Others; By Services Offered; By Mode of Transportation; By Holding Temperature Range; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Cell and Gene Therapy Cold Chain Logistics Market Outlook
The global cell and gene therapy cold chain logistics market size was valued at USD 1.85 billion in 2023, driven by the increasing adoption of cell and gene therapies and advancements across the globe. The market is anticipated to grow at a CAGR of 15.6% during the forecast period of 2024-2032 to achieve a value of USD 6.81 billion by 2032.
Cell and Gene Therapy Cold Chain Logistics: Introduction
Cell and gene therapies are used to treat diseases and disorders by using living cells and genetic material. Cell and gene therapy are the latest and uniquely designed techniques to treat people with certain medical conditions and disorders. A particular cold chain logistics is required to store and handle all the genetic material that is going to be stored in them.
Global Cell and Gene Therapy Cold Chain Logistics Market Analysis
Packaging logistics are specifically designed to reduce the temperature fluctuations and to maintain the required environment for a long time in terms of temperature. Cryogenic shippers and insulated containers, that provide required temperature control during the process of transportation, are also under development and are likely to aid the global cell and gene therapy cold chain logistics market growth in the coming years.
Additionally, increasing focus on monitoring and data management in order to achieve real-time monitoring systems and data management platforms is also a key trend in the market. This plays an important part in making sure that the integrity of cell and gene therapies is intact.
Global Cell and Gene Therapy Cold Chain Logistics Market Segmentations
Market Breakup by Component
- Cryogenic Shippers
- Cryogenic Storage Freezers
- Ultra Low Freezers
- Cold Chain Management Systems
- Shipment and Storage Medium
- Cryogenic Packout Kits
- Others
Market Breakup by Services Offered
- Transportation
- Storage
- Packaging
Market by Mode of Transportation
- Air
- Ground
- Water
Market Breakup by Holding Temperature Range
- Cryogenic
- Refrigerated
- Ambient
- Others
Market Breakup by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Cell and Gene Therapy Cold Chain Logistics Market Overview
The growth of the market is primarily driven by the rising adoption of cell and gene therapy cold chain logistics in the healthcare sector. The increasing advancements in regenerative medicine are directly contributing to the efficient cold chain logistics solutions. Another key feature is the rising presence of several key players, who are offering specialized services in cell and gene therapy cold chain logistics. The availability of such services is significantly driving the market growth.
The growth of the market is also driven by the rapid developments by logistics and transportation companies, packaging manufacturers, monitoring and data management solution providers, among others. The market for cell and gene therapy cold chain logistics is an important part of the healthcare industry, which is enabling the safe and efficient delivery of innovative treatments. The global cell and gene therapy cold chain logistics market demand is expected to witness continuous growth and development due to the increasing adoption of these therapies and advancements.
Global Cell and Gene Therapy Cold Chain Logistics Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- BioLife Solutions, Inc.
- United Parcel Service (Marken)
- AmerisourceBergen Corporation (World Courier)
- Catalent, Inc.
- Atelerix Ltd.
- Cryoport, Inc.
- Biostor Ltd.
- Thermo Fisher Scientific Inc.
- Life Science Group Ltd (LSG)
- Yourway Biopharma Services Company
- Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
- Be The Match BioTherapies
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Component |
|
| Breakup by Services Offered |
|
| Breakup by Mode of Transportation |
|
| Breakup by Holding Temperature Range |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cell and Gene Therapy Cold Chain Logistics Market Overview
3.1 Global Cell and Gene Therapy Cold Chain Logistics Market Historical Value (2017-2023)
3.2 Global Cell and Gene Therapy Cold Chain Logistics Market Forecast Value (2024-2032)
4 Global Cell and Gene Therapy Cold Chain Logistics Market Landscape
4.1 Global Cell and Gene Therapy Cold Chain Logistics Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cell and Gene Therapy Cold Chain Logistics Product Landscape
4.2.1 Analysis by Component
4.2.2 Analysis by Services Offered
4.2.3 Analysis by Mode of Transportation
4.2.4 Analysis by Holding Temperature Range
5 Global Cell and Gene Therapy Cold Chain Logistics Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cell and Gene Therapy Cold Chain Logistics Market Segmentation
6.1 Global Cell and Gene Therapy Cold Chain Logistics Market by Component
6.1.1 Market Overview
6.1.2 Cryogenic Shippers
6.1.3 Cryogenic Storage Freezers
6.1.4 Ultra Low Freezers
6.1.5 Cold Chain Management Systems
6.1.6 Shipment and Storage Medium
6.1.7 Cryogenic Packout Kits
6.1.8 Others
6.2 Global Cell and Gene Therapy Cold Chain Logistics Market by Services Offered
6.2.1 Market Overview
6.2.2 Transportation
6.2.3 Storage
6.2.4 Packaging
6.3 Global Cell and Gene Therapy Cold Chain Logistics Market by Mode of Transportation
6.3.1 Market Overview
6.3.2 Air
6.3.3 Ground
6.3.4 Water
6.4 Global Cell and Gene Therapy Cold Chain Logistics Market by Holding Temperature Range
6.4.1 Market Overview
6.4.2 Cryogenic
6.4.3 Refrigerated
6.4.4 Ambient
6.4.5 Others
6.5 Global Cell and Gene Therapy Cold Chain Logistics Market by End User
6.5.1 Market Overview
6.5.2 Pharmaceutical and Biotechnology Companies
6.5.3 Academic and Research Institutes
6.5.4 Others
6.6 Global Cell and Gene Therapy Cold Chain Logistics Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Cell and Gene Therapy Cold Chain Logistics Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cell and Gene Therapy Cold Chain Logistics Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cell and Gene Therapy Cold Chain Logistics Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cell and Gene Therapy Cold Chain Logistics Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cell and Gene Therapy Cold Chain Logistics Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 BioLife Solutions, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 United Parcel Service (Marken)
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 AmerisourceBergen Corporation (World Courier)
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Catalent, Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Atelerix Ltd.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Cryoport, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Biostor Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Thermo Fisher Scientific Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Life Science Group Ltd (LSG)
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Yourway Biopharma Services Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Be The Match BioTherapies
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
18 Global Cell and Gene Therapy Cold Chain Logistics Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.85 billion in 2023, driven by the increasing advancements in regenerative medicine.
What is the global cell and gene therapy cold chain logistics market forecast outlook for 2024-2032?
The market is anticipated to grow at a CAGR of 15.6% during the forecast period of 2024-2032 and reach a market value of USD 6.81 billion by 2032.
The rising advancement in regenerative medicine and increased adoption of cell and gene therapies across the globe are some of the major factors aiding the global market growth.
The increasing adoption of cell and gene therapies is a key trend in the market.
The different type of components in the market are cryogenic shippers, cryogenic storage freezers, ultra-low freezers, cold chain management systems, shipment and storage medium, and cryogenic pack out kits, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is a major regional market.
The services offered in the market can be categorized into transportation, storage, and packaging.
The modes of transportation can be categorized into air, ground, and water.
The holding temperature range can be divided into cryogenic, refrigerated, and ambient, among others.
The end-users in the market include pharmaceutical and biotechnology companies, and academic and research institutes, among others.
Key players included in the market are BioLife Solutions, Inc., United Parcel Service (Marken), AmerisourceBergen Corporation (World Courier), Catalent, Inc., Atelerix Ltd., Cryoport, Inc., Biostor Ltd., Thermo Fisher Scientific Inc., Life Science Group Ltd (LSG), Yourway Biopharma Services Company, Bertelsmann SE & Co. KGaA (Arvato Supply Chain Solutions), and Be The Match BioTherapies.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER